BioSafe Medical Technologies
Received $18,000,000 in multiple financing rounds for working capital and development from
Whitman-Hart, et.al.
FOCUS Regional Managing Partner William S. Lear assisted in the negotiations as the representative of BioSafe Medical Technologies.
Securities transactions conducted by FOCUS Securities LLC, an affiliated company, registered broker dealer and member FINRA/SIPC.
Home | About Us | Services | Sector Expertise | Deals Publications | News | Privacy Policy | Site Map | Contact Us